Journal of Infection and Public Health
Volume 3, Issue 2 , Pages 67-75 , 2010

Evaluation of a school-based program for diagnosis and treatment of latent tuberculosis infection in immigrant children

  • Philippe Minodier

      Affiliations

    • Infectious Diseases Division, Department of Pediatrics, CHU Sainte Justine – Université de Montréal, 3175 Côte Sainte Catherine, Montréal, QC, Canada H3T 1C5
    • Pediatric Emergency, CHU Nord, Chemin des Bourrelly, 13015 Marseille, France
    • ,
  • Valérie Lamarre

      Affiliations

    • Infectious Diseases Division, Department of Pediatrics, CHU Sainte Justine – Université de Montréal, 3175 Côte Sainte Catherine, Montréal, QC, Canada H3T 1C5
    • ,
  • Marie-Eve Carle

      Affiliations

    • Intercultural Pediatric Unit, Department of Pediatrics, CHU Sainte Justine – Université de Montréal, 3175 Côte Sainte Catherine, Montréal, QC, Canada H3T 1C5
    • ,
  • Denis Blais

      Affiliations

    • Infectious Diseases Division, Department of Pediatrics, CHU Sainte Justine – Université de Montréal, 3175 Côte Sainte Catherine, Montréal, QC, Canada H3T 1C5
    • ,
  • Philippe Ovetchkine

      Affiliations

    • Infectious Diseases Division, Department of Pediatrics, CHU Sainte Justine – Université de Montréal, 3175 Côte Sainte Catherine, Montréal, QC, Canada H3T 1C5
    • ,
  • Bruce Tapiero

      Affiliations

    • Infectious Diseases Division, Department of Pediatrics, CHU Sainte Justine – Université de Montréal, 3175 Côte Sainte Catherine, Montréal, QC, Canada H3T 1C5
    • Intercultural Pediatric Unit, Department of Pediatrics, CHU Sainte Justine – Université de Montréal, 3175 Côte Sainte Catherine, Montréal, QC, Canada H3T 1C5
    • Corresponding Author InformationCorresponding author at: Intercultural Pediatric Unit, Department of Pediatrics, CHU Sainte Justine–Université de Montréal, 3175 Côte Sainte Catherine, Montréal, QC, Canada H3T 1C5. Tel.: +1 514 345 4931; fax: +1 514 345 4822.

Received 14 January 2010 ,Revised 5 February 2010 ,Accepted 8 February 2010.

References 

  1. Pediatric Tuberculosis Collaborative Group . Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics. 2004;114:1175–1201
  2. Wobeser W, Yuan L, Gushulak B. Surveillance and screening in tuberculosis control. In:  Long R,  Ellis E editor. Canadian tuberculosis standards. 6th ed.. Ottawa, ON: Minister of Health; 2007;p. 274–297
  3. Horsburgh CR. Priorities for the treatment of latent tuberculosis infection in the United States. N Eng J Med. 2004;350:2060–2067
  4. American Thoracic Society . Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221–S247
  5. Comité Québécois sur la tuberculose. Epidémiologie de la tuberculose au Québec de 2000 à 2003. ed. Québec, QC: Ministère de la Santé et des Services Sociaux du Québec; 2005.
  6. Portrait des populations immigrante et non immigrante, 2001. Arrondissement Côte-des-Neiges-Notre-Dame-de-Grâce. http://ville.montreal.qc.ca [updated July 2008].
  7. Kitai I, Malloy P, Kowalczyk A. Pediatric tuberculosis. In:  Long R,  Ellis E editor. Canadian tuberculosis standards. 6th ed.. Ottawa, ON: Minister of Health; 2007;p. 182–199
  8. Yuan L, Richardson E, Kendall PRW. Evaluation of a tuberculosis screening program for high-risk students in Toronto schools. Can Med Assoc J. 1995;153:925–932
  9. Doering D, Kocuipchyk R, Lester S. A tuberculosis screening and chemoprophylaxis project in children from a high risk population in Edmonton, Alberta. Can J Public Health. 1999;90:152–155
  10. Bibi H, Weiler-Ravell D, Shoseyov D. Compliance to treatment of latent tuberculosis infection in a region of Israel. Isr Med Assoc J. 2002;4:13–16
  11. Hovell MF, Sipan CL, Blumberg EJ. Increasing Latino adolescents’ adherence to treatment for latent tuberculosis infection: a controlled trial. Am J Public Health. 2003;93:1871–1877
  12. Coly A, Morisky D. Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis in Los Angeles. Int J Tuberc Lung Dis. 2004;8:703–710
  13. Marais BJ, Van Zyl S, Schaaf HS. Adherence to isoniazid preventive chemotherapy: a prospective community based study. Arch Dis Child. 2006;91:762–765
  14. Van Zyl S, Marais BJ, Hesseling AC. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis. 2006;10:13–18
  15. Brassard P, Steensma C, Cadieux L. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country. Pediatrics. 2006;117:e148–e156
  16. Menzies D, Khan K. Diagnosis of tuberculosis infection and disease. In:  Long R,  Ellis E editor. Canadian tuberculosis standards. 6th ed.. Ottawa, ON: Minister of Health; 2007;p. 53–91
  17. Center for Disease Control and Prevention . Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR. 2000;49(RR-6):26–39
  18. Hoeppner VH, Ward H, Elwood K. Treatment of tuberculosis disease and infection. In:  Long R,  Ellis E editor. Canadian tuberculosis standards. 6th ed.. Ottawa, ON: Minister of Health; 2007;p. 114–145
  19. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report 2007. Geneva: World Health Organization (WHO/HTM/TB/2007.376).
  20. Scholten JN, Fujiwara PI, Frieden TR. Prevalence and factors associated with tuberculosis infection among new school entrants, New York City, 1991–1993. Int J Tuberc Lung Dis. 1999;3:31–41
  21. Gounder CR, Driver CR, Scholten JN. Tuberculin testing and risk of tuberculosis infection among New York City schoolchildren. Pediatrics. 2003;111:e309–e315
  22. Reznik M, Ozuah PO. Tuberculin skin testing in children. Emerg Infect Dis. 2006;12:725–728
  23. Mohle-Boetani JC, Miller B, Halpern M. School-based screening for tuberculosis infection. A cost–benefit analysis. J Am Med Assoc. 1995;274:613–619
  24. Henry PM, Mills WA, Holtan NR. Screening for tuberculosis infection among secondary school students in Minneapolis-St Paul: policy implications. Minn Med. 1996;79:43–49
  25. Pong AL, Bronwen JA, Moser KS. Tuberculosis screening at 2 San Diego high schools with high-risk populations. Arch Pediatr Adolesc Med. 1998;152:646–650
  26. Saiman L, San Gabriel P, Schulte J. Risk factors for latent tuberculosis infection among children in New York City. Pediatrics. 2001;107:999–1003
  27. Young J, O’Connor ME. Risk factors associated with latent tuberculosis infection in Mexican American children. Pediatrics. 2005;115:e647–e653
  28. Chang S, Wheeler LSM, Farrell KP. Public health impact of targeted tuberculosis screening in public schools. Am J Public Health. 2002;92:1942–1945
  29. Menzies D, Chan CH, Vissandjée B. Impact of immigration on tuberculosis infection among Canadian-born schoolchildren and young adults in Montreal. Am J Respir Crit Care Med. 1997;156:1915–1921
  30. Froehlich H, Ackerson LM, Morozumi PA. Targeted testing of children for tuberculosis: validation of a risk assessment questionnaire. Pediatrics. 2001;107:e54
  31. Ozuah PO, Ozuah TP, Stein REK. Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children. J Am Med Assoc. 2001;285:451–453
  32. Fos PJ, Lee JH, Zuniga MA. The role of quality improvement in disease management: a statewide tuberculosis control success story. J Public Health Manage Pract. 2005;11:222–227
  33. Levesque JF, Dongier P, Brassard P. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugees claimants in Canada. Int J Tuberc Lung Dis. 2004;8:711–717
  34. Lavigne M, Rocher I, Steensma C. The impact of smoking on adherence for latent tuberculosis infection. BMC Public Health. 2006;6:66
  35. Menzies D, Dion MJ, Francis D. In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection. Int J Tuberc Lung Dis. 2005;9:1343–1348
  36. Ailinger RL, Moore JB, Nguyen N. Adherence to latent tuberculosis infection therapy among Latino immigrants. Public Health Nurs. 2006;23:307–313
  37. Goldberg SV, Wallace J, Jackson JC. Cultural case management of latent tuberculosis infection. Int J Tuberc Lung Dis. 2004;8:76–82
  38. Shieh FK, Snyder G, Horsburgh CR. Predicting non-completion of treatment for latent tuberculous infection. A prospective survey. Am J Respir Crit Care Med. 2006;174:717–721
  39. LoBue PA, Moser KD. Use of isoniazid for latent tuberculosis infection in a Public Health Clinic. Am J Respir Crit Care Med. 2003;168:443–447
  40. Nyamathi A, Stein JA, Schumann A. Latent variable assessment of outcomes in a nurse-managed intervention to increase latent tuberculosis treatment completion in homeless adults. Health Psychol. 2007;26:68–76
  41. Carvalho ACC, Saleri N, El-Hamad I. Completion of screening for latent tuberculosis infection among immigrants. Epidemiol Infect. 2005;133:179–185
  42. Shukla SJ, Warren DK, Woeltje KF. Factors associated with the treatment of latent tuberculosis infection among health-care workers at Midwestern Teaching Hospital. Chest. 2002;122:1609–1614
  43. Parsyan AE, Saukkonen J, Barry MA. Predictors of failure to complete treatment for latent tuberculosis infection. J Infect. 2007;54:262–266
  44. Morisky DE, Ebin VJ, Malotte CK. Assessment of tuberculosis treatment completion in an ethnically diverse population using two data sources. Implications for treatment interventions. Eval Health Prof. 2003;26:43–58
  45. Hovell M, Blumberg E, Gil-Trejo L. Predictors of adherence to treatment for latent tuberculosis infection in high-risk Latino adolescents: a behavioral epidemiological analysis. Soc Sci Med. 2003;56:1789–1796
  46. Berg J, Blumberg EJ, Sipan CL. Somatic complaints and isoniazid (INH) side effects in Latino adolescents with latent tuberculosis infection (LTBI). Patient Educ Couns. 2004;52:31–39
  47. Cass AD, Talavera GA, Gresham LS. Structured behavioral intervention to increase children's adherence to treatment for latent tuberculosis infection. Int J Tuberc Lung Dis. 2005;9:415–420
  48. Kominski GF, Varon SF, Morisky DE. Costs and cost-effectiveness of adolescent compliance with treatment for latent tuberculosis infection: results from a randomized trial. J Adolesc Health. 2007;40:61–68
  49. Nyamathi AM, Christiani A, Nahid P. A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection. Int J Tuberc Lung Dis. 2006;10:775–782
  50. Spyridis NP, Spyridis PG, Gelesme A. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampicin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis. 2007;45:715–722
  51. Ena J, Valls V. Short-course therapy with rifampicin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis. 2005;40:670–676
  52. Taylor REB, Cant AJ, Clark JE. Potential effect of NICE tuberculosis guidelines on paediatric tuberculosis screening. Arch Dis Child. 2008;93:200–203
  53. Drobniewski F, Cobelens F, Zellweger JP, et al. Use of gamma-interferon assays in low- and medium-prevalence countries in Europe: a consensus statement of Wolfheze Workshop organised by KNCV/EuroTB, Vilnius Sept 2006. Euro Surveill 2007;12(30):pii=3242. http://www.eurosurveillance.org/ew/2007/070726.asp#2 [updated July 2008].

PII: S1876-0341(10)00005-5

doi: 10.1016/j.jiph.2010.02.001

Journal of Infection and Public Health
Volume 3, Issue 2 , Pages 67-75 , 2010

Article Tools

* Image Usage & Resolution